Advanced Cell Therapy Trials 2018 - 2019Q2

Package of ALL advanced cell therapy trials registered internationally from beginning of 2018 through middle of 2019 contains 19 columns of data for 743+363 = 1106 trials. The sample file contains more than two trials for each month. Customers will receive free updates if we later find more trials in this time frame.

# Trials/Month advanced cell therapy

TRENDS 2017 - 2019Q2:

  • There were 630 Trials total in 2017 and 743 in 2018
  • From 2017 to 2018, the # Trials/Month rose 17%
  • For the first half of 2019 there are 363 trials & average # Trials/Month is 61, the same as 2018
  • During 2018 the trials were 57% / 43% between Cellular Immunotherapy and Regenerative Medicine
  • For the first half of 2019 the breakdown is again 57% / 43% for Immunotherapy / Regen Med
  • The monthly fraction of trials outside ClinicalTrials.gov averaged 23% in 2017, 38% in 2018, and 27% in the first half of 2019.

Excel File Columns

  • Trial Data
    • Registration Month
    • Registration Year (2018)
    • Trial ID with link to trial on-line
    • Country
    • Phase
    • Status 
  • Cell Data
    • Type of therapy: Immunotherapy or Regenerative
    • Cell Type
    • Cell Source
    • Route of Administration
    • Cell Dose
  • Patient Data
    • Indication
    • Donor Autologous or Allogeneic
    • Target Enrollment
    • Patient Age Groups
  • Sponsor Data
    • Academia or Industry Funding
    • Sponsor Name and any Collaborators
    • Study Name (if any)
    • Product Name (if any)

 

Public samples: